SEC Comment Letter 0000000000-23-008114 to SOLENO THERAPEUTICS INC (SLNO) (CIK 0001484565) (SLNO)
SOLENO THERAPEUTICS INC (SLNO) (CIK 0001484565)
Date: July 28, 2023 · CIK: 0001484565 · Accession: 0000000000-23-008114
AI Filing Summary & Sentiment
File numbers found in text: 333-273373
Letter
United States securities and exchange commission logo July 28, 2023 James Mackaness Chief Financial Officer Soleno Therapeutics, Inc. 203 Redwood Shores Parkway, Suite 500 Redwood City, CA 94065 Re:Soleno Therapeutics, Inc. Registration Statement on Form S-1 Filed July 21, 2023 File No. 333-273373 Dear James Mackaness: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Abby Adams at (202) 551-6902 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Jesse Schumaker
Show Raw Text
United States securities and exchange commission logo
July 28, 2023
James Mackaness
Chief Financial Officer
Soleno Therapeutics, Inc.
203 Redwood Shores Parkway, Suite 500
Redwood City, CA 94065
Re:Soleno Therapeutics, Inc.
Registration Statement on Form S-1
Filed July 21, 2023
File No. 333-273373
Dear James Mackaness:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Abby Adams at (202) 551-6902 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Jesse Schumaker